Atrys Health (Spain) Performance
| ATRY Stock | EUR 2.99 0.01 0.33% |
The firm shows a Beta (market volatility) of 0.32, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Atrys Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Atrys Health is expected to be smaller as well. At this point, Atrys Health SL has a negative expected return of -0.0743%. Please make sure to confirm Atrys Health's value at risk, skewness, and the relationship between the maximum drawdown and potential upside , to decide if Atrys Health SL performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Atrys Health SL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Atrys Health is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 17.5 M | |
| Total Cashflows From Investing Activities | -2.4 M |
Atrys |
Atrys Health Relative Risk vs. Return Landscape
If you would invest 316.00 in Atrys Health SL on October 31, 2025 and sell it today you would lose (17.00) from holding Atrys Health SL or give up 5.38% of portfolio value over 90 days. Atrys Health SL is generating negative expected returns and assumes 1.8237% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Atrys, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Atrys Health Target Price Odds to finish over Current Price
The tendency of Atrys Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.99 | 90 days | 2.99 | about 29.93 |
Based on a normal probability distribution, the odds of Atrys Health to move above the current price in 90 days from now is about 29.93 (This Atrys Health SL probability density function shows the probability of Atrys Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Atrys Health has a beta of 0.32. This suggests as returns on the market go up, Atrys Health average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Atrys Health SL will be expected to be much smaller as well. Additionally Atrys Health SL has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Atrys Health Price Density |
| Price |
Predictive Modules for Atrys Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Atrys Health SL. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Atrys Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Atrys Health is not an exception. The market had few large corrections towards the Atrys Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Atrys Health SL, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Atrys Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.2 | |
β | Beta against Dow Jones | 0.32 | |
σ | Overall volatility | 0.19 | |
Ir | Information ratio | -0.14 |
Atrys Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Atrys Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Atrys Health SL can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Atrys Health SL generated a negative expected return over the last 90 days | |
| Atrys Health SL has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 121.01 M. Net Loss for the year was (23.25 M) with profit before overhead, payroll, taxes, and interest of 27.78 M. | |
| About 78.0% of the company shares are held by company insiders |
Atrys Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Atrys Stock often depends not only on the future outlook of the current and potential Atrys Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atrys Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.5 M | |
| Cash And Short Term Investments | 40.6 M |
Atrys Health Fundamentals Growth
Atrys Stock prices reflect investors' perceptions of the future prospects and financial health of Atrys Health, and Atrys Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Atrys Stock performance.
| Return On Equity | -0.0723 | |||
| Return On Asset | 0.0022 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 647.57 M | |||
| Shares Outstanding | 75.89 M | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 2.47 X | |||
| Revenue | 121.01 M | |||
| EBITDA | 6.88 M | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 146.81 M | |||
| Debt To Equity | 0.95 % | |||
| Book Value Per Share | 4.67 X | |||
| Cash Flow From Operations | 4.69 M | |||
| Earnings Per Share | (0.46) X | |||
| Total Asset | 565.63 M | |||
About Atrys Health Performance
By analyzing Atrys Health's fundamental ratios, stakeholders can gain valuable insights into Atrys Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Atrys Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Atrys Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 525 people.Things to note about Atrys Health SL performance evaluation
Checking the ongoing alerts about Atrys Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Atrys Health SL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Atrys Health SL generated a negative expected return over the last 90 days | |
| Atrys Health SL has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 121.01 M. Net Loss for the year was (23.25 M) with profit before overhead, payroll, taxes, and interest of 27.78 M. | |
| About 78.0% of the company shares are held by company insiders |
- Analyzing Atrys Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Atrys Health's stock is overvalued or undervalued compared to its peers.
- Examining Atrys Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Atrys Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Atrys Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Atrys Health's stock. These opinions can provide insight into Atrys Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Atrys Stock analysis
When running Atrys Health's price analysis, check to measure Atrys Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atrys Health is operating at the current time. Most of Atrys Health's value examination focuses on studying past and present price action to predict the probability of Atrys Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atrys Health's price. Additionally, you may evaluate how the addition of Atrys Health to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |